Commentary: In search of answers regarding the benefits and harms of short term ADT for intermediate-risk prostate cancer
Department of Radiation Oncology, University of Virginia School of Medicine, Charlottesville, Virginia, USA
Feb
2017 (Vol.
24, Issue
1, Pages(
8663 - 8663)
PMID: 28263133